Complications of Common Gynecologic Surgeries among HIV-Infected Women in the United States by Penman-Aguilar, Ana et al.
Hindawi Publishing Corporation
Infectious Diseases in Obstetrics and Gynecology




among HIV-Infected Womenin the UnitedStates
AnaPenman-Aguilar,1 MauraK. Whiteman,1 ShannaCox,1 SamuelF.Posner,1
Susan F. Meikle,2 Athena P. Kourtis,1 andDenise J. Jamieson1
1National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention,
4770 Buford Highway-Mailstop K-34, Atlanta, GA 30341, USA
2The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health,
Building 31, Room 2A32, MSC 2425, 31 Center Drive, Bethesda, MD 20892, USA
Correspondence should be addressed to Ana Penman-Aguilar, bpv4@cdc.gov
Received 31 January 2012; Revised 12 March 2012; Accepted 16 March 2012
Academic Editor: Gregory T. Spear
Copyright © 2012 Ana Penman-Aguilar et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Objective. To compare frequencies of complications among HIV-infected and-uninfected women undergoing common
gynecologicalsurgicalproceduresininpatientsettings.Methods.Weused1994–2007datafromtheNationwideInpatientSampleof
the Healthcare Cost and Utilization Project, a nationally representative sample of inpatient hospitalizations. Our analysis included
discharge records of women aged ≥15 undergoing hysterectomy, oophorectomy, salpingectomy for ectopic pregnancy, bilateral
tubal sterilization, or dilation and curettage. Associations between HIV infection status and surgical complications were evaluated
in multivariable logistic regression models, adjusting for key covariates. Results. For each surgery, HIV infection was associated
with experiencing ≥1 complication. Adjusted ORs ranged from 2.0 (95% conﬁdence interval (CI): 1.7, 2.2) for hysterectomy with
oophorectomy to 3.1 (95% CI: 2.4, 4.0) for bilateral tubal sterilization with no comorbidity present. HIV infection was positively
associated with extended length of stay and infectious complications of all of the surgeries examined. For some surgeries, it was
positively associated withtransfusionand anemia due toacute bloodloss.AmongHIV-infected women, the oddsof infectious and
other complications did not decrease between 1994–2000 and 2001–2007. Conclusion. HIV infection was associated with elevated
frequencies of complications of gynecologic surgeries in the US, even in the era of HAART.
1.Introduction
Until recently, most general obstetrician-gynecologists in
the United States (US) had little opportunity to provide
care to HIV-infected women. Screening guidelines published
in 2006 and 2008 [1, 2] and advances in treatment have
changed the landscape of treatment and care of HIV-infected
women. As more women test positive for HIV and as HIV-
infected women live longer, healthier lives [3], increasing
numbers of women of reproductive age will be living with
anHIVdiagnosis,andgeneralobstetrician-gynecologistswill
increasingly encounter women who have been diagnosed
with HIV infection. Recognizing the increased need for
informationandguidanceforprovidingoptimalgynecologic
care for HIV-infected women, the American College of
Obstetricians and Gynecologists recently published a prac-
tice bulletin on the topic [4].
The literature on the risk of postoperative complications
among HIV-infected patients is mixed. For example, a
large retrospective study of surgical outcomes that used
data from the Kaiser Permanente Medical Care Program
revealedgreater12-monthmortalityandgreaterincidenceof
post-operativepneumonia;however,nootherpost-operative
complications were elevated among HIV-infected patients
[5].Notably,despiteHIV-infectedwomenhavinganelevated
risk for some conditions leading to gynecologic surgery [6–
10], little systematic evidence is available on the risk of
complications of gynecologic surgeries among HIV-infected
women. The few reports that exist are inconsistent in their
ﬁndings with one study observing a signiﬁcantly higher2 Infectious Diseases in Obstetrics and Gynecology
rate of complications among HIV-infected women [11]
and two other studies yielding null results [12, 13]. The
objective of this analysis is to add to the knowledge base
by describing complications among HIV-positive women
undergoing certain common gynecological surgeries. We
used national data from the US to compare frequencies of
complications among HIV-infected and-uninfected women
undergoing common gynecological surgical procedures in
inpatient settings.
2.MaterialsandMethods
We used data from the Nationwide Inpatient Sample (NIS)
from 1994–2007. We included several years of data in order
to have a suﬃcient number of discharge records among HIV-
infectedwomentocreatereliableestimatesforselectedsurgi-
cal procedures. The Healthcare Cost and Utilization Project
(HCUP) includes databases and software tools developed
throughapartnershipamongprivateindustry,states,andthe
federal government. The NIS, the largest all-payer database
of inpatient stays in the United States, is a key component
of HCUP. The NIS incorporates data from approximately
8 million hospital stays per year, and it approximates a
20% stratiﬁed sample of community hospitals in the US
(AHRQ, 2010). Sampling is stratiﬁed on location (rural
or urban), hospital size, region of the country, teaching
status, and type of ownership (public or private). As of
2007, 40 states contributed data to the NIS, and hospitals
in the sampling frame comprised approximately 90% of US
hospital discharges [14].
We analyzed discharge records from women aged 15
and older, excluding hospitalizations that included delivery
(International Classiﬁcation of Diseases, 9th revision, Clin-
ical Modiﬁcation (ICD-9-CM) codes 650; V27). We further
limited the study population to include only hospitalizations
during which one of the following procedures had been
performed: oophorectomy (procedure codes 65.3, 65.31,
65.39, 65.4, 65.41, 65.49, 65.5, 65.51, 65.52, 65.53, 65.54,
65.6, 65.61, 65.62, 65.63, and 65.64), salpingectomy for
ectopic pregnancy (procedure code 66.62), bilateral tubal
sterilization (procedure codes 66.2, 66.21, 66.22, 66.29,
66.3, 66.31, 66.32, and 66.39), dilation and curettage (pro-
cedure codes 69.0, 69.01, 69.02, and 69.09) or hysterec-
tomy. Hysterectomy was deﬁned as abdominal hysterectomy
(68.3, 68.39, 68.4, and 68.49), vaginal hysterectomy (68.5;
68.59), or total laparoscopic hysterectomy/laparoscopic-
assisted hysterectomy (68.31, 68.41, and 68.51). Any type
of hysterectomy with the code 54.21 was also coded as
laparoscopic-assisted. We focused on these gynecologic sur-
gical procedures because they were the most common (at
least 150 surgeries performed) among hospitalizations of
HIV-infected women in our dataset. With the exception of
hysterectomy with concomitant oophorectomy, we excluded
hospitalizations during whichmultiple gynecologic surgeries
wereperformed.TheNISdoesnotincludepatientidentiﬁers,
and the unit of analysis is the hospital discharge record.
Although some patients may have been admitted multiple
times during the study period for procedures we examined,
w ee x p e c tt h i st ob er a r e .
Our primary outcome, experiencing at least one compli-
cation of surgical procedures, was deﬁned as experiencing
extended length of stay; transfusion; anemia due to acute
blood loss; accidental puncture or laceration during a pro-
cedure; hemorrhage, hematoma, or seroma complicating a
procedure; urinary tract infection; fever; other postoperative
infection; urinary tract complications including urinary
retention and ureteral obstruction; paralytic ileus; any of
several less common complications (e.g., thromboembolism
and postoperative shock). Extended length of stay was
deﬁned as being at or above the 90th percentile for that
speciﬁc surgical procedure. This was equivalent to ≥5d a y s
for hysterectomy with oophorectomy, ≥4f o rh y s t e r e c t o m y
alone, ≥9 for oophorectomy alone, ≥4 for salpingectomy for
ectopicpregnancy, ≥5forbilateraltubalsterilization,and ≥6
for dilation and curettage. Other complications were deﬁned
based on relevant ICD-9 codes.
Our primary independent variable was HIV status (ICD-
9-CM codes 042, 043, 044, 079.53, 279.10, 279.19 795.71,
795.8, and V08). We deﬁned comorbidity as presence of
≥1 of the following conditions/behaviors that could put
womenatincreasedriskforcomplicationsofthegynecologic
surgeries we examined: obesity, diabetes, cardiac condition
or hypertension, anemia, gastrointestinal ulcers, smoking,
and alcohol or substance abuse. Based on review of the
literature, we selected relevant ICD-9 codes for these condi-
tions/behaviors, and we deﬁned them accordingly.
We compared discharge records of HIV-infected and
-uninfected women undergoing the gynecologic surger-
ies we examined on various descriptive characteristics of
patients and hospitals, including age, primary payer, hospital
teaching status/location, hospital region, and presence of any
comorbidity. Race was not examined because some states
do not report race/ethnicity data, and, among states that do
reportthis,thereareofteninconsistenciesandmissingvalues
in the data. Comparisons were evaluated with chi-squared
tests (alpha = 0.05).
For each surgery, we used multivariable logistic regres-
sion to estimate the association between HIV infection status
and experiencing ≥1 complication of surgery, adjusting
for patient age, primary payer, year of hospitalization, and
presence of any comorbidity. Because of the possibility that
associations between HIV infection status and the occur-
rence of complications might diﬀer depending on whether
comorbidity was present, we tested for interaction between
HIV infection status and presence of any comorbidity.
Associations for which statistically signiﬁcant interaction
was detected (alpha = 0.05) are presented separately for
women with and without comorbidity. In addition, we
conducted multivariable logistic regression to estimate the
association between HIV infection and the 4 most common
complications in our sample. These included extended
length of stay, transfusion, anemia due to blood loss, and
all infectious complications combined (i.e., experience of
urinary tract infection; fever; other postoperative infection;
or contaminated or infected blood, other ﬂuid, drug, or
biological substance). Again, we adjusted models for patient
age, primary payer, year of hospitalization, and presence
of comorbidity, and we tested for interaction between HIVInfectious Diseases in Obstetrics and Gynecology 3
infection and any comorbidity. Finally, for each surgery we
examined, we tested for major shifts over time by using
multivariable logistic regression (with adjustment for the
samevariables),tocompare,forhospitalizations amongHIV
infected women, the odds of extended length of stay, infec-
tious complications, and all other complications combined
during the time periods preceding (1994–2000) and during
(2001–2007) widespread implementation of highly active
antiretroviral treatment (HAART) in the US.
We used SAS-callable SUDAAN 9.0 software (RTI Inter-
national, Research Triangle, Durham, NC, USA) to account
for the multistage probability sampling design. All results
are based on weighted estimates of hospitalizations in the
US during the period of study. In 1998, the NIS sample
designchangedtobetterreﬂectthepopulationofhospitalsin
the sample. Speciﬁcally, short-term rehabilitation hospitals
were excluded, stratiﬁcation variables were redeﬁned, the
discharge deﬁnition was changed, and previous-year NIS
hospitals were no longer given sampling precedence. To
account for the change in sample design, we applied an
alternate set of NIS discharge and hospital weights (based on
the 1998 design) to 1994–1997 data [15]. All programming
was independently duplicated by a second data analyst.
Because the study utilized deidentiﬁed data from a publicly
available data set, the Centers for Disease Control and
Prevention determined that human-subject research review
was not required.
3. Results
During the years 1994–2007, there were an estimated
14,922,397 surgeries of interest (hysterectomy, oophorec-
tomy, salpingectomy for ectopic pregnancy, bilateral tubal
sterilization, or dilation and curettage) among women aged
15 and older. Excluding delivery hospitalizations (n =
4,303,344)andhospitalizationsduringwhichmorethanone
of the gynecologic surgeries we examined were performed
(n = 1,682,573) resulted in an analytic sample of an
estimated 8,939,780 surgeries, 18,177 of which were among
HIV-infected women, and 8,921,603 of which were among
HIV-uninfected women.
The distribution of type of gynecological surgery diﬀered
among hospitalizations of HIV-infected and-uninfected
women,withbilateraltubalsterilization(12.6%versus3.4%)
and dilation and curettage (12.7% versus 6.8%) being
more common among HIV-infected women in our sample
(Table 1). For hospitalizations that included hysterectomy,
the distribution of surgical approach also varied according to
the woman’s HIV infection status. Regardless of whether an
oophorectomy was performed concomitantly, HIV-infected
women in our sample more often underwent abdominal
hysterectomies (87.0% versus 82.6% for hysterectomy with
oophorectomy and 61.8% versus 55.9% for hysterectomy
alone). Laparoscopic hysterectomy was performed less often
among HIV-infected women (9.3% versus 11.1% for hys-
terectomy with oophorectomy and 8.3% versus 12.7% for
hysterectomy alone). Compared to HIV-uninfected women,
HIV-infectedwomenhospitalizedforgynecologicalsurgeries
were more often under 35 years of age (34.6% versus 20.6%),
less often relied on private insurance as the primary payment
source (29.1% versus 69.6%), more often received care in
urban teaching hospitals (67. 7% versus 42.5%) and in the
southern or northeastern US (83.7% versus 57.6%). HIV-
infected women more often presented with comorbidity
(44.7% versus 34.1%).
For hysterectomy with or without oophorectomy,
oophorectomy without hysterectomy, salpingectomy, and
dilation and curettage, HIV infection was positively associ-
atedwithexperiencing ≥1complicationofsurgeryinmodels
adjusted for age, primary payer, year, and presence of comor-
bidity (Table 2). However, for bilateral tubal sterilization, the
association between HIV infection status and experiencing
≥1 complication diﬀered according to whether comorbidity
was present (interaction P value < 0.001), and HIV infection
was positively associated with experiencing complications
only among women without comorbidity. The magnitude
of the association between HIV infection and experiencing
≥1 complication ranged from two-fold for hysterectomy
with oophorectomy (adjusted odds ratio (aOR): 2.0; 95%
conﬁdence interval (CI): 1.7, 2.2) to more than three-fold
for bilateral tubal sterilization in the absence of comorbidity
(aOR: 3.1; 95% CI: 2.4, 4.0).
When we examined the eﬀect of HIV infection on the
occurrence of common speciﬁc complications, we found
that HIV infected women were more likely than uninfected
women to experience infectious complications of all the
gynecologicsurgeriesweexamined(Table 3).Theyalsomore
often experienced an extended length of stay following
these surgeries. However, for bilateral tubal sterilization, the
a s s o c i a t i o nb e t w e e nH I Vi n f e c t i o na n de x t e n d e dl e n g t ho f
stay diﬀered by the presence of comorbidity (interaction
P value < 0.001); HIV-infected women more often experi-
enced extended length of stay only when comorbidity was
absent. For the following types of surgery, transfusion was
more often performed on HIV-infected women than HIV-
uninfected women: hysterectomy without oophorectomy,
bilateral tubal sterilization, and dilation and curettage. For
dilation and curettage, but not for the other types of
gynecologic surgeries we examined, HIV-infected women
more often experienced anemia due to acute blood loss.
Among hospitalizations of HIV-infected women, there
were no statistically signiﬁcant changes from 1994–2000 to
2001–2007 in the frequency of any of the three groups of
complications we examined for changes over time (extended
length of stay, infectious complications, and all others
combined).
4. Discussion
HIV infection was associated with elevated frequencies
of surgical complications of the gynecologic surgeries we
examined. Not only was positive HIV status associated with
experiencing any of several surgical complications, but it also
showed higher frequencies of speciﬁc complications such as
needing to undergo transfusion. In most cases, the presence
ofcomorbiditydidnotaltertheassociationbetweenHIVand
surgical complications. Overall, we observed an increased4 Infectious Diseases in Obstetrics and Gynecology
Table 1: Demographic and hospitalization characteristics, surgical procedure and approach, and presence of comorbidity among selected
gynecological surgeries, by HIV status (United States, 1994–2007).
Characteristic
HIV-Infected N = 18,177 HIV-Uninfected N = 8,921,603 P value
n percentage n percentage
Patient age
15–34 6297 34.64 1836185 20.58
<0.001 35–44 7539 41.48 3235700 36.27
45–54 3549 19.53 2361684 26.47
55+ 792 4.36 1488034 16.68
Any comorbidity∗
Yes 8123 44.69 3040273 34.08 <0.001
Primary payer∗∗
Medicare 2109 11.64 939970 10.57
<0.001 Medicaid 8255 45.55 1040880 11.71
Private Insurer 5276 29.11 6190159 69.63
Other 2483 13.7 718531 8.08
Hospital teaching status/location†
Rural 964 5.31 1349712 15.16
<0.001 Urban nonteaching 4901 27.01 3772124 42.37
Urban teaching 12279 67.67 3781486 42.47
Hospital region
Northeast 5512 30.32 1555612 17.44
<0.001 Midwest 1928 10.61 2070666 23.21
South 9703 53.38 3583074 40.16
West 1034 5.69 1712251 19.19
Surgical procedure (approach)
Hysterectomy with concomitant
oophorectomy†† 6546 36.01 4314430 48.36
<0.001‡
(Abdominal) (5693) (86.97) (3561463) (82.55)
(Vaginal) (247) (3.77) (272811) (6.32)
(Laparoscopic) (606) (9.26) (480157) (11.13)
Hysterectomy alone†† 4591 25.26 2235199 25.05
(Abdominal) (2836) (61.77) (1248765) (55.87)
(Vaginal) (1373) (29.90) (703311) (31.47)
(Laparoscopic) (382) (8.33) (283122) (12.67)
Oophorectomy alone 1841 10.13 1214082 13.61
Salpingectomy for ectopic pregnancy 609 3.35 252689 2.83
Bilateral tubal sterilization 2290 12.60 302380 3.39
Dilation and curettage 2301 12.66 602823 6.76
∗Including obesity, diabetes, cardiac condition or hypertension, asthma, anemia, gastrointestinal ulcers, smoking, and alcohol or substance abuse.
∗∗N = 8,907,664 due to missing values.
†N = 8,921,466.
††P value for surgical approach < 0.001.
‡P value for surgical procedure.Infectious Diseases in Obstetrics and Gynecology 5
Table 2: Estimated numbers of speciﬁc procedures, percentages with any complication, and adjusted odds ratios for experiencing at least













oophorectomy 6546 37.47 4314430 24.95 2.0 (1.7, 2.2)
Hysterectomy without
oophorectomy 4591 41.4 2235199 20.8 2.3 (2.0, 2.6)
Oophorectomy without
hysterectomy 1841 44.64 1214082 28.33 2.6 (2.1, 3.2)
Salpingectomy for ectopic
pregnancy 609 50.56 252689 29.93 2.2 (1.5, 3.2)
Bilateral tubal sterilization‡
Any comorbidity 811 36.07 54514 31.56 1.2 (0.9, 1.7)
No comorbidity 1478 38.4 247866 15.97 3.1 (2.4, 4.0)
Dilation and curettage 2301 54.23 602823 29.64 2.8 (2.3, 3.4)
∗Complications include extended length of stay; accidental puncture or laceration during procedure; hemorrhage, hematoma, or seroma complicating a
procedure; anemia due to acute blood loss; transfusion; urinary tract infection; fever; other postoperative infection; urinary tract complications including
urinary retention and ureteral obstruction; paralytic ileus; thromboembolism; postoperative shock; disruption of operation wound; postoperative ﬁstula;
hypotension; cardiac arrest; respiratory arrest; foreign body left during procedure; acute reaction to foreign substance accidentally left duringap r o c e d u r e ;
failure of sterile precautions during procedure; failure in dosage; mechanical failure of instrument or apparatus during procedure; contaminated or infected
blood, other ﬂuid, drug, or biological substance; removal of other organ (partial or total); nonspeciﬁed other complications of medical care; other
complications of procedures.
†Adjusted for patient age (modeled as continuous), primary payer (private insurance versus other), year of hospitalization (modeled as continuous),a n d
presence of any comorbidity (obesity, diabetes, cardiac condition or hypertension, asthma, anemia, gastrointestinal ulcers, smoking, and alcoholo rs u b s t a n c e
abuse).
‡Results are presented separately depending on the presence of comorbidity due to statistically signiﬁcant interaction between HIV status and comorbidity.
occurrence of complications among HIV-infected women
undergoing gynecologic surgeries.
Comorbidity altered the association between HIV status
and surgical complications of bilateral tubal sterilization.
Among women who had this procedure, the frequency of
experiencing at least one complication was essentially equal
among HIV-infected and-uninfected women with any of the
comorbiditiesweexamined;however,whencomorbiditywas
absent, HIV-infected women more often experienced at least
one complication. We suspect that, for tubal sterilization,
which is a relatively minor procedure, comorbidity may be
more important than HIV status in putting women at risk of
surgical complications. Nevertheless, HIV status appeared to
play an important role among women without comorbidity;
among these women, HIV infection was associated with
increased occurrence of complications. This is consistent
with the increased occurrence of complications that we
observed for other surgical procedures. Notably, abdom-
inal approaches were more often used (and laparoscopic
approaches less often used) among HIV-infected women
in our sample who underwent hysterectomy, as compared
to uninfected women who underwent hysterectomy. This
likely contributed to the increased frequency of surgical
complications that we observed among HIV-infectedwomen
undergoing hysterectomy.
Little has been published on complications of gyneco-
logic surgical procedures among HIV-infected women. A
study by Grupert and colleagues included 235 gynecologic
and obstetric surgeries among HIV-infected women [11].
They reported a higher complication rate among HIV-
infected women, as compared to HIV-negative controls.
Another study by Franz and colleagues [12] reviewed the
hospital course of 24 HIV-infected patients who underwent
hysterectomy and compared them to uninfected controls,
ﬁnding that HIV-infected women and controls did not diﬀer
on complication rates. Sewell and colleagues reviewed 53
surgical procedures among HIV-infected women [13]. They
foundthatHIV-infectedwomenhadapproximatelytwicethe
odds of experiencing complications (17% of HIV-infected
women versus 9% of controls); however, these results did
not achieve statistical signiﬁcance, perhaps because of small
sample size. In contrast, we examined associations between
infection with HIV and frequency of complications of
selected gynecologic surgeries in a large nationally repre-
sentative database, and we observed statistically signiﬁcant
associations between HIV infection status and experiencing
complications.
Our study has some limitations. We did not have
information on the stage of women’s HIV disease. Although
frequencies of complications were higher among HIV-
infected women, we could not determine the extent to
which this was due to immunosuppression. Additionally,
the NIS dataset includes only inpatient hospitalizations.
Our ﬁndings are, therefore, only applicable to inpatient
settings; results in other settings may diﬀer. Finally, the
quality of our data is dependent on the accuracy of diagnoses6 Infectious Diseases in Obstetrics and Gynecology
Table 3: Estimated percentages with speciﬁc complications∗ and adjusted odds ratios for experiencing complications, by HIV status, among
selected gynecological surgeries (United States, 1994–2007).







oophorectomy (n = 6546) (n = 4314430)
Extended length of stay 25.70 13.25 2.8( 2 .4, 3.2)
Transfusion 9.37 3.74 †
Anemia due to acute blood loss 5.25 5.75 1.1( 0 .9, 1.4)
Infectious complications†† 8.83 4.24 2.3( 1 .9, 2.9)
Hysterectomy without oophorectomy (n = 4591) (n = 2235199)
Extended length of stay 31.63 11.45 2.7( 2 .4, 3.2)
Transfusion 8.57 2.98 2.2( 1 .7, 2.8)
Anemia due to acute blood loss 5.40 4.99 1.1( 0 .8, 1.4)
Infectious complications 8.06 3.14 2.4( 1 .9, 3.0)
Oophorectomy without hysterectomy (n = 1841) (n = 1214082)
Extended length of stay 23.49 11.91 4.3( 3 .3, 5.7)
Transfusion 8.86 4.73 †
Anemia due to acute blood loss 5.46 5.50 1.3( 0 .9, 2.1)
Infectious complications 11.94 6.19 2.2( 1 .6, 3.0)
Salpingectomy for ectopic pregnancy (n = 609) (n = 252689)
Extended length of stay 31.02 11.79 3.0( 2 .0, 4.4)
Transfusion 16.48 9.69 1.7( 0 .9, 2.9)
Anemia due to acute blood loss 13.76 14.36 1.0( 0 .5, 1.8)
Infectious complications 8.77 3.07 2.6( 1 .4, 4.8)
Bilateral tubal sterilization (n = 2290) (n = 302380)
Among women with any comorbidity,
extended length of stay‡ 29.08 23.12 1.4( 1 .0, 2.0)
Among women with no comorbidity,
extended length of stay‡ 32.00 9.22 4.4( 3 .4, 5.6)
Transfusion 5.01 1.62 2.3( 1 .5, 3.6)
Anemia due to acute blood loss 3.59 3.73 0.9( 0 .6, 1.5)
Infectious complications 7.41 2.57 2.3( 1 .6, 3.3)
Dilation and curettage (n = 2301) (n = 602823)
Extended length of stay 27.68 11.04 3.6( 2 .9, 4.5)
Transfusion 26.15 10.95 2.7( 2 .1, 3.6)
Anemia due to acute blood loss 15.47 9.91 1.8( 1 .4, 2.3)
Infectious complications 6.61 4.31 1.8( 1 .2, 2.7)
∗We present the 4 complications that were most common in our sample.
∗∗Adjusted for patient age (modeled as continuous), primary payer (private insurance versus other), year of hospitalization (modeled as continuous),a n d
presence of any comorbidity (obesity, diabetes, cardiac condition or hypertension, asthma, anemia, gastrointestinal ulcers, smoking, and alcoholo rs u b s t a n c e
abuse).
†No valid model could be generated (i.e., model did not converge).
††Infectious complications included urinary tract infection; fever; other postoperative infection; and contaminated or infected blood, other ﬂuid,d r u g ,o r
biological substance.
‡Results are presented separately depending on the presence of comorbidity due to statistically signiﬁcant interaction between HIV status and comorbidity.Infectious Diseases in Obstetrics and Gynecology 7
and procedures listed in discharge records. Some of the
conditions and behaviors that we classiﬁed as comorbidity
may have been characterized by diﬀerential accuracy or
completeness, depending on a woman’s HIV status. For
example, a provider may have been more or less likely to
ascertain substance abuse and note it in the medical record,
depending on a woman’s HIV status.
Despite these limitations, our study had important
strengths. It is based on a large, nationwide data set, making
our ﬁndings more generalizable to inpatient gynecologic
surgeries across the US. The numbers of women undergoing
surgeries in our analysis exceeded those in earlier studies.
The large sample size allowed for the ability to detect
associations that may have been missed in other studies.
Finally, unlike the earlier studies we cited, we sought to
account for the relationship between HIV and comorbidity
in putting women at risk for complications of gynecologic
surgery.
5. Conclusions
In conclusion, the issue of HIV infection in gynecological
treatment and care will become more prominent as more
women in the US screen positive for HIV [4], and treatment
a d d sy e a r st ow o m e n ’ sl i v e s[ 3]. Our study adds to the
evidence that HIV infection is an important consideration
in gynecologic treatment and care. Adequately powered
prospective studies that examine factors that put HIV-
infected women at higher risk of surgical complications,
and that identify potentially modiﬁable risk factors, are
needed. Results of such studies can inform development of
prevention strategies to protect the health of HIV-infected
women, and help reduce disparities between HIV-infected
and -uninfected women in complications of gynecologic
surgeries.
Our ﬁnding that the frequency of infectious and other
surgical complications among hospitalizations of HIV-
infected women did not decrease following widespread
implementation of HAART suggests that women’s access
to and adherence to treatment for HIV disease could be
improved. Strategies for improving access and adherence
to HAART should be developed, evaluated, and prioritized.
Additionally, the high proportion of HIV-infected women in
our sample with comorbidities underscores the importance
of health providers being well prepared to address a wide
range of medical comorbidities as well as behaviors that
may negatively impact the health of HIV-infected women.
Treatment by multidisciplinary teams of providers may be
another approach for ensuring that the health needs of HIV-
infected women are addressed.
Disclaimer
The ﬁndings and conclusions in this report are those of the
authors and do not necessarily represent the oﬃcial position
of the Centers for Disease Control and Prevention.
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